This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nanjing Heron Pharmaceutical Science and Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Yunqing Feng in Pharmaceutical Science
Introduction
Yunqing Feng is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of new drug formulations. His work focuses on improving the efficacy and safety of existing medications.
Latest Patents
Yunqing Feng holds a patent for a ketorolaco derivative, which is a pharmaceutical composition and preparation method. This innovative derivative demonstrates a better half-life and stability, along with improved pharmacokinetic properties. The ketorolaco derivative enhances efficacy while reducing toxicity, addressing common issues associated with traditional ketorolaco preparations, such as frequent administration and gastrointestinal side effects.
Career Highlights
Yunqing Feng is associated with Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. His work at this company has been pivotal in advancing pharmaceutical technologies. He has successfully developed formulations that improve patient compliance and therapeutic outcomes.
Collaborations
Yunqing Feng collaborates with esteemed colleagues, including Hai Ye and Tao Min. Their combined expertise contributes to the innovative research and development efforts at their company.
Conclusion
Yunqing Feng's contributions to pharmaceutical science exemplify the importance of innovation in improving drug formulations. His work not only enhances the effectiveness of medications but also prioritizes patient safety and compliance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile